Literature DB >> 27270405

Free Fatty Acids Increase Intracellular Lipid Accumulation and Oxidative Stress by Modulating PPARα and SREBP-1c in L-02 Cells.

Shumin Qin1, Jinjin Yin2, Keer Huang3.   

Abstract

Excessive fat accumulation and increased oxidative stress contribute to the pathogenesis of nonalcoholic fatty liver disease (NAFLD). However, the mechanisms underlying the development of steatosis are not entirely understood. The present study was undertaken to establish an experimental model of hepatocellular steatosis with a fat overaccumulation profile in which the effects of oxidative stress could be studied in L-02 cells. We investigated the effects of free fatty acids (FFA) (palmitate:oleate, 1:2) on lipid accumulation and oxidative stress and their possible mechanisms in L-02 cells. High concentrations of fatty acids significantly induced excessive lipid accumulation and oxidative stress in L-02 cells, which could only be reversed with 50 μΜ WY14643 (the PPARα agonist). Immunoblotting and qPCR analyses revealed that FFA downregulated the expression of proliferator-activated receptor alpha (PPARα), which contributed to the increased activation of sterol regulatory element binding protein-1c (SREBP-1c). These results suggest that FFA induce lipid accumulation and oxidative stress in L-02 cells by upregulating SREBP-1c expression through the suppression of PPARα.

Entities:  

Keywords:  Free fatty acids; Hepatic steatosis; L-02 cell line; Nonalcoholic fatty liver disease; PPARα; SREBP-1c

Mesh:

Substances:

Year:  2016        PMID: 27270405     DOI: 10.1007/s11745-016-4160-y

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  31 in total

Review 1.  Fatty liver: role of inflammation and fatty acid nutrition.

Authors:  Christopher D Byrne
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2010-03-02       Impact factor: 4.006

Review 2.  Modulation of sterol regulatory element binding proteins (SREBPs) as potential treatments for non-alcoholic fatty liver disease (NAFLD).

Authors:  Mohamed H Ahmed; Christopher D Byrne
Journal:  Drug Discov Today       Date:  2007-08-27       Impact factor: 7.851

3.  Herbacetin induces apoptosis in HepG2 cells: Involvements of ROS and PI3K/Akt pathway.

Authors:  Yan Qiao; Qisen Xiang; Li Yuan; Li Xu; Zhigang Liu; Xuebo Liu
Journal:  Food Chem Toxicol       Date:  2012-10-12       Impact factor: 6.023

4.  Resveratrol inhibits the expression of SREBP1 in cell model of steatosis via Sirt1-FOXO1 signaling pathway.

Authors:  Guang-Li Wang; Yu-Cai Fu; Wen-Can Xu; Ya-Qing Feng; Shi-Rong Fang; Xiao-Hui Zhou
Journal:  Biochem Biophys Res Commun       Date:  2009-01-31       Impact factor: 3.575

5.  Molecular mechanisms of (-)-epicatechin and chlorogenic acid on the regulation of the apoptotic and survival/proliferation pathways in a human hepatoma cell line.

Authors:  Ana Belén Granado-Serrano; María Angeles Martín; María Izquierdo-Pulido; Luis Goya; Laura Bravo; Sonia Ramos
Journal:  J Agric Food Chem       Date:  2007-02-08       Impact factor: 5.279

6.  Amelioration by chicory seed extract of diabetes- and oleic acid-induced non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH) via modulation of PPARα and SREBP-1.

Authors:  Nasrin Ziamajidi; Shahnaz Khaghani; Gholamreza Hassanzadeh; Safura Vardasbi; Shahram Ahmadian; Azin Nowrouzi; Seyed Mahmood Ghaffari; Afshin Abdirad
Journal:  Food Chem Toxicol       Date:  2013-04-18       Impact factor: 6.023

7.  Human hepatocellular carcinoma cell lines secrete the major plasma proteins and hepatitis B surface antigen.

Authors:  B B Knowles; C C Howe; D P Aden
Journal:  Science       Date:  1980-07-25       Impact factor: 47.728

Review 8.  Non-alcoholic fatty liver disease pathogenesis: the present and the future.

Authors:  S Petta; C Muratore; A Craxì
Journal:  Dig Liver Dis       Date:  2009-02-14       Impact factor: 4.088

Review 9.  Peroxisome proliferator-activated receptor alpha target genes.

Authors:  S Mandard; M Müller; S Kersten
Journal:  Cell Mol Life Sci       Date:  2004-02       Impact factor: 9.261

Review 10.  Human hepatocytes in primary culture: the choice to investigate drug metabolism in man.

Authors:  M J Gómez-Lechón; M T Donato; J V Castell; R Jover
Journal:  Curr Drug Metab       Date:  2004-10       Impact factor: 3.731

View more
  13 in total

1.  Intake of stigmasterol and β-sitosterol alters lipid metabolism and alleviates NAFLD in mice fed a high-fat western-style diet.

Authors:  Simin Feng; Zhuqing Dai; Anna B Liu; Jinbao Huang; Nihal Narsipur; Grace Guo; Bo Kong; Kenneth Reuhl; Wenyun Lu; Zisheng Luo; Chung S Yang
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2018-08-07       Impact factor: 4.698

2.  Dietary Flaxseed Oil Prevents Western-Type Diet-Induced Nonalcoholic Fatty Liver Disease in Apolipoprotein-E Knockout Mice.

Authors:  Hao Han; Fubin Qiu; Haifeng Zhao; Haiying Tang; Xiuhua Li; Dongxing Shi
Journal:  Oxid Med Cell Longev       Date:  2017-09-07       Impact factor: 6.543

3.  Transcriptomic analysis of the hepatic response to stress in the red cusk-eel (Genypterus chilensis): Insights into lipid metabolism, oxidative stress and liver steatosis.

Authors:  Sebastian Naour; Brisa M Espinoza; Jorge E Aedo; Rodrigo Zuloaga; Jonathan Maldonado; Macarena Bastias-Molina; Herman Silva; Claudio Meneses; Cristian Gallardo-Escarate; Alfredo Molina; Juan Antonio Valdés
Journal:  PLoS One       Date:  2017-04-27       Impact factor: 3.240

Review 4.  The Impact of Environmental Factors in Influencing Epigenetics Related to Oxidative States in the Cardiovascular System.

Authors:  Francesco Angelini; Francesca Pagano; Antonella Bordin; Marika Milan; Isotta Chimenti; Mariangela Peruzzi; Valentina Valenti; Antonino Marullo; Leonardo Schirone; Silvia Palmerio; Sebastiano Sciarretta; Colin E Murdoch; Giacomo Frati; Elena De Falco
Journal:  Oxid Med Cell Longev       Date:  2017-05-14       Impact factor: 6.543

5.  The Combination of Blueberry Juice and Probiotics Ameliorate Non-Alcoholic Steatohepatitis (NASH) by Affecting SREBP-1c/PNPLA-3 Pathway via PPAR-α.

Authors:  Tingting Ren; Juanjuan Zhu; Lili Zhu; Mingliang Cheng
Journal:  Nutrients       Date:  2017-02-27       Impact factor: 5.717

Review 6.  Mitophagy in Hepatic Insulin Resistance: Therapeutic Potential and Concerns.

Authors:  Zuqing Su; Yutong Nie; Xiufang Huang; Ying Zhu; Bing Feng; Lipeng Tang; Guangjuan Zheng
Journal:  Front Pharmacol       Date:  2019-10-10       Impact factor: 5.810

7.  The pharmacodynamic and differential gene expression analysis of PPAR α/δ agonist GFT505 in CDAHFD-induced NASH model.

Authors:  Linfu Liu; Chuang Liu; Manyu Zhao; Qianru Zhang; Ying Lu; Ping Liu; Hua Yang; Jinliang Yang; Xiaoxin Chen; Yuqin Yao
Journal:  PLoS One       Date:  2020-12-16       Impact factor: 3.240

8.  Huperzine A attenuates nonalcoholic fatty liver disease by regulating hepatocyte senescence and apoptosis: an in vitro study.

Authors:  Xiao-Na Hu; Jiao-Feng Wang; Yi-Qin Huang; Zheng Wang; Fang-Yuan Dong; Hai-Fen Ma; Zhi-Jun Bao
Journal:  PeerJ       Date:  2018-06-26       Impact factor: 2.984

9.  Direct free radical scavenging effects of water-soluble HMG-CoA reductase inhibitors.

Authors:  Ryohei Umeda; Hiroki Takanari; Kazue Ogata; Shigekiyo Matsumoto; Takaaki Kitano; Katsushige Ono; Osamu Tokumaru
Journal:  J Clin Biochem Nutr       Date:  2018-08-08       Impact factor: 3.114

Review 10.  Changes in lipids composition and metabolism in colorectal cancer: a review.

Authors:  Alicja Pakiet; Jarosław Kobiela; Piotr Stepnowski; Tomasz Sledzinski; Adriana Mika
Journal:  Lipids Health Dis       Date:  2019-01-26       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.